Merck & Co., Inc.
Merck & Co., Inc. (MRK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MRK · as of Jun 8, 2026
Key Statistics
Explore Merck & Co., Inc. Data
mrk stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 37 · Buy rate: 67.6%
The MRK analyst consensus is Buy, based on ratings from 37 Wall Street analysts over the past 3 months. The average 12-month price target is $130.69, representing +8.20% upside from the current price of $120.79.
Competitors & Peers
mrk competitorsMRK
ABT
AMGN
AZN
GILD
GSKStock Performance
Full HistoryAbout Merck & Co., Inc.
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products…
what is merck & co., inc. · mrk stock overview · merck & co., inc. company profile · who is merck & co., inc. ceo · mrk NYSE · merck & co., inc. headquarters · merck & co., inc. business segments
About Stock Overview & Key Data
Merck & Co., Inc. (MRK) is a Healthcare company in the Drug Manufacturers - General industry, listed on NYSE since Jan 13, 1978. As of the latest trading session, MRK stock price is $120.79, with a market capitalization of $298.3B. The stock has returned +52.26% over the past 12 months and +14.75% year-to-date.
According to 37 Wall Street analysts, the consensus rating for Merck & Co., Inc. stock is Buy, with an average 12-month price target of $130.69. In fiscal year 2025, Merck & Co., Inc. reported revenue of $64.9B and net income of $18.3B. For detailed data — including Merck & Co., Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Merck & Co., Inc. (MRK) stock price is $120.79. The stock is traded on NYSE under the ticker symbol MRK. The 52-week range is $76.66 – $125.14.